New drug INI-4001 takes on advanced cancers in early trial
NCT ID NCT06302426
First seen Jan 24, 2026 · Last updated May 15, 2026 · Updated 23 times
Summary
This early-phase study tests a new drug called INI-4001, alone or with standard immunotherapy, in people with advanced solid tumors that have spread. The main goal is to find a safe dose and check for side effects. About 50 adults with various cancers that cannot be cured with current treatments will participate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cabrini Hospital
RECRUITINGMalvern, Victoria, 3144, Australia
Contact Email: •••••@•••••
Contact
-
Southern Oncology Clinical Research Unit
RECRUITINGBedford Park, South Australia, 5042, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Border Cancer Hospital
RECRUITINGAlbury, New South Wales, 2640, Australia
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.